comparemela.com

Latest Breaking News On - Clinical trials rules - Page 8 : comparemela.com

Regular market approval granted for Covishield, Covaxin for use in adult population

Firms to submit data of ongoing clinical trials and vaccines to be supplied for programmatic setting

United kingdomV krishna mohanPrakash kumar singhRegulatory affairsBharat biotech international limitedDrug administrationCentral drugs standard control organisationRegulatory agencyUnion governmentExpert committeeSerum institute of indiaNew drugsClinical trials rulesDrugs controller generalSubject expert committeeSerum institute

DCGI grants regular market approval to Covishield, Covaxin, details here

These Covid-19 vaccines will not be available in medical stores.

New delhiMansukh mandaviyaNational pharmaceutical pricing authoritySerum institute of indiaExpert committeeCentral drugs standard control organisationDrugs controller generalMinister mansukh mandaviyaNew drugsClinical trials rulesSubject expert committeeSerum instituteBharat biotechEmergency use authorisationCovid 19 vaccineCovid 19

Covid Vaccine: Covishield, Covaxin To Be Available In Hospitals In New Approval: Sources

Covishield and Covaxin have been cleared by India's drugs regulator for sale in the market, sources have said.

V krishna mohanPrakash kumar singhRegulatory affairsSerum institute of indiaCovaxin to be available in hospitalsClinics in new approvalDrugs controller generalNew drugsClinical trials rulesBharat biotechSerum instituteKumar singhHyderabad based bharat biotechCovid vaccine in indiaCovid 19 vaccine in indiaCovid vaccine efficacy

Bharat Biotech, Serum to submit data on ongoing clinical trials overseas: Govt

Despite over 160 crore doses of both the COVID-19 vaccines combined administered in India, the manufacturers will have to be under a strict screening of the government for safety profiles and efficacy of their vaccines.

United statesUnited kingdomUnion health ministryDrug administrationIndian council of medical researchCentral drugs standard control organizationRegulatory agencyExpert committeeSerum institute of indiaBharat biotechSerum instituteDrugs controller generalStringent regulatory authoritiesUnited states foodSubject expert committeeAdverse event following immunization

Shot in the Back: PM CARES Hasn t Given Rs 100 Crore to Develop COVID Vaccines

None of the departments associated with India's COVID-19 vaccine development efforts received any money from the fund.

New delhiNarendra modiCommodore lokesh batraK vijayraghavanPm care fundVaccine administration cellCentral drug standards control organisationIndian council of medical researchDepartment of biotechnologyPrime minister narendra modiPrime ministerPrincipal scientific advisorCentral public information officerAdministration cellIndian councilMedical research

vimarsana © 2020. All Rights Reserved.